Katherine Vega Stultz's most recent trade in Kronos Bio Inc was a trade of 68,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kronos Bio Inc | Katherine Vega Stultz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jun 2025 | 68,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kronos Bio Inc | Katherine Vega Stultz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jun 2025 | 34,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kronos Bio Inc | Katherine Vega Stultz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jun 2025 | 7,079 | 0 | - | - | Stock Option (Right to Buy) | |
| Kronos Bio Inc | Katherine Vega Stultz | Director | 25 Jun 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | ||
| Kronos Bio Inc | Katherine Vega Stultz | Director | 22 Jun 2023 | 7,079 | 7,079 | - | - | Stock Option (Right to Buy) | ||
| Kronos Bio Inc | Katherine Vega Stultz | Director | 10 Apr 2023 | 68,000 | 68,000 | - | - | Director Stock Option (Right to Buy) |